FeverTree

Ticker: FEVR LN

Sector: Spirits

Rating: Buy

Published Research

FeverTree: H1 Showed Costs are On Track, Even if Growth is Not (Yet) (September 2024)

FeverTree: Long-Term Compounder; Takeover Potential Not Priced In (Initiation) (June 2024)